CSI Market
Sign In | Register

Nemaura Medical Inc (NMRD) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access NMRD Annual Cash Flow →
Quarterly cash flow trends provide additional context on Nemaura Medical Inc's liquidity and ability to support ongoing operations and capital needs.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2023)
9 Months 		(Sep 30 2023) (Jun 30 2023) (Mar 31 2023) (Dec 31 2022)
Operating Activities
Income-5.97
Depreciation & amortization0.31
Amortization of Other Assets1.80
Increase (Decrease) in Deferred Revenue0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase-1.92
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Paid-in-Kind Interest0.49
Monitoring Fee Interest Expense Added To Notes Payable-
Fees For Note Amendments Expense Added To Note Payable-
Impairment Of Intangible Assets Excluding Goodwill-
Change In Fair Value Of Foreign Exchange Contract-
Changes In Fair Value Of Warrant Liability-
Change In Fair Value Of Foreign Exchange Contract Derivative Liability.-0.49
Change In Fair Value Of Warrant Liability-2.60
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable0.03
Increase (Decrease) in Accounts Payable0.03
Increase (Decrease) in Other Accrued Liabilities0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets1.11
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-7.20
Investing Activities
Capital Expenditures-0.08
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Fixed Rate Savings Account-
Proceeds From Fixed Rate Savings Account-
Increase (Decrease) in Restricted Cash and Investments0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.08
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments6.50
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Cash Costs Incurred In Relation To Atm Financing-
Cash Costs Incurred In Relation To Public Offering-
Gross Proceeds From Issuance Of Common Stock In Relation To Atm Financing-
Costs Incurred In Relation To Atm Financing-
Costs Incurred In Relation To Public Offering-
Costs Incurred In Relation To Atm Equity Financing-
Costs Incurred In Relation To Equity Financing-
Repayments Of Insurance Financing-
Commission Paid On Note Payable-
Principal Payments On Note Payable-
Principal Payments On Notes Payable-9.18
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-2.68
Effect of exchange rate on cash flow-0.01
Discontinued operations0.00
Free Cash Flow-7.28
Total Cash Flow-9.96
4 historic quarters locked

Sign in to unlock the full Nemaura Medical Inc cash flow history.

Sign In Create Free Account

About Nemaura Medical Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20231231)
  • Filed with the SEC: February 12, 2024
  • Source: nmrd_10q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001079973-24-000215

Figures are derived from filed reports and may be restated. Historical data is subject to revision.